Do statins affect blood sugar? On what basis?

Introduction: Do statins affect blood sugar? The answer to this question is that it may cause an increase in blood sugar levels in the body to a certain extent. <>

Statins can affect the rise in blood sugar to some extent. Statins are mainly used in medicine to reduce the amount of lipids in the blood and cholesterol in the blood. However, it is also possible to cause an increase in blood sugar levels, so we need to measure blood sugar after taking statins.

If the sugar returns to normal after stopping the drug, then the blood sugar in the patient's body is not affected by the statin. Statins may affect blood sugar levels, but they do not necessarily affect blood sugar levels. And the effect of the drug will not be fast, which means that most people will not have significant changes in blood sugar after taking statins, but some people will still be affected by the increase in blood sugar.

The reason why patients have increased blood sugar after taking statins is mainly related to the level of blood lipids in the body. When the content of blood lipids in the human body decreases, the body's feedback system will detect that the content of blood lipids will decrease, and blood glucose and blood lipids can be converted into each other, that is, they can complement each other to maintain the normal steady state of blood lipids and blood sugar in the human body. In the same way, if the storage content of blood lipids in the human body is reduced, then part of the glucose in the blood will be converted into fat to replenish the content of blood lipids in the blood to maintain balance.

For some people with diabetes or high blood pressure, the blood sugar levels in the body may be affected by statins and the blood sugar levels may rise. It can be seen that statins are not able to raise blood sugar for most people, but for some special groups, it is possible to affect blood sugar levels and thus rise. That said, statins can affect blood sugar.

Statins are a type of lipid-lowering drug, and long-term use of statins may cause blood sugar to rise. To determine whether a statin raises blood sugar, you can measure your blood sugar while taking a statin, stop taking the statin for a period of time, and observe changes in blood sugar.

If the blood sugar returns to normal after stopping, and the blood sugar rises again after taking the statin again, it can be determined that the statin blood sugar raiser is indeed there. For statins to raise blood sugar, can diabetic patients still take statins if they have coronary heart disease, high blood pressure, cerebral infarction and other diseases?

The answer is yes.

For diabetic patients, taking statins is necessary for the condition, if there is coronary heart disease, cerebral infarction, obesity, kidney disease, etc., it is necessary to take statins, which not only have the effect of lowering blood lipids, but also stabilize atherosclerotic plaques and prevent cerebral infarction and myocardial infarction.

Therefore, although statins have a certain phenomenon of raising blood sugar, according to the needs of the condition, it is necessary to continue to take statins, and at the same time, blood glucose monitoring can be controlled by adjusting the dosage of hypoglycemic drugs to achieve blood sugar standards.

Statins usually don't cause blood sugar to rise. If you take more statins, you can lower your blood lipids, i.e., lower triglycerides, cholesterol, and LDL. Some of them can cause transaminases.

However, it does not cause an increase in blood sugar, because it affects the metabolism of blood lipids, so it sometimes causes bloating, that is, eating will be reduced.

Statins can affect blood sugar and will raise blood sugar, because statin drugs have a certain effect on pancreatic islets, so they will definitely affect blood sugar.

As the most classic and effective lipid-lowering drug, statin is widely used in people with hyperlipidemia, statin can reduce elevated plasma total cholesterol, low-density lipoprotein, apolipoprotein B and triglycerides. The effectiveness of statins in the prevention and treatment of cardiovascular and cerebrovascular diseases has opened up a new era in the prevention and treatment of chronic diseases, so how to correctly use statins in patients with hyperlipidemia?

Lipid lowering** is a long-term process, and for the vast majority of older patients who initiate statins**, they need to continue taking statins even if their lipids return to normal. Moreover, for diabetic patients, patients with coronary heart disease, and patients with atherosclerosis, the blood lipid control target needs to be lower than the upper limit of normal blood lipid levels, and blood lipid levels should be measured regularly.

Most users tolerate statins well, usually mild and transient, including headaches, insomnia, and digestive symptoms such as indigestion, diarrhea, and nausea, which generally do not need to be discontinued if tolerated.

Therefore, before using statins, it is necessary to assess the patient's risk of developing diabetes, and for people with diabetes who are at higher risk, taking statins requires dietary and lifestyle interventions, overweight or obesity**, and close monitoring of blood glucose and glycosylated hemoglobin. In the choice of drug, pravastatin and pitavastatin, or ezetimibe may be considered.

No. Especially for people with high blood lipids, they should not be separated from statins. Statins are originally lipid-lowering drugs. And the blood lipids have decreased, which is also helpful for blood sugar control.

Because people with three highs need to take other drugs, statin drugs are very easy to have a bad effect on other drugs, and the damage to the liver is particularly great, so it is better to listen to the doctor.

This kind of population really should stay away from statins, as this medication may make their condition worse or even produce ***.

Yes, statins have been shown to cause high blood sugar and may cause memory loss, which can be restored after stopping the drug. However, the U.S. Food and Drug Administration requires that reports of high blood sugar that may be caused by taking the drug must be included in the label and instructions of statins.

Recently, the US Food and Drug Administration (FDA) has made major revisions to the instructions of statins that regulate blood lipids, deleted the requirements for daily monitoring of liver enzymes during drug administration, and added new adverse reaction information and drug interaction information.

The risk of statins possibly causing hyperglycemia and cognitive abnormalities has been a concern recently, with the U.S. Food and Drug Administration (FDA) announcing in February that statin-related memory loss and confusion are reversible after discontinuation of the drug, and reports of hyperglycemia have been added to statin labeling instructions.

At present, there are no new regulations on statins in China.

Statins cause an increase in blood sugar and need your attention.

Sugar friends take statins, *** be careful. When taking drugs, we still need to know more about whether there will be some adverse reactions.

Method steps.

Taking statins with certain drugs can aggravate adverse effects Most of the patients taking statins have coronary heart disease and arrhythmias, and they may be taking drugs such as amiodarone, verapamil, and diltiazem, which are metabolized in the liver in the same way as some statins, which may increase the adverse effects of statins and even cause serious adverse reactions: rhabdomyolysis. There are also several drugs such as itraconazole, ketoconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine, danazol, which also interact with statins.

Therefore, when initiating statins, be sure to inform your doctor about the various medications you are taking.

Myopathy is characterized by muscle aches, tenderness, tenderness, weakness, and is common in elderly patients with frailty, emaciation, and renal insufficiency.

Elevated liver enzymes This is usually short-term transient and occurs within the first 1 to 3 months of the onset of **, mainly with an increase in alanine aminotransferase, which mostly returns to normal.

Abnormal blood glucose is manifested by elevated fasting blood glucose levels, elevated glycosylated hemoglobin levels, new-onset diabetes mellitus, and poor glycemic control in diabetic erythropathy. Therefore, patients who take statins for a long time should pay attention to whether they have unprovoked muscle aches and weakness, dry mouth and polydipsia, and should regularly check creatine muscle enzymes, liver enzymes and fasting blood glucose, generally once every three months.

Precautions.

Answer] :d biggest risk of taking statins is rhabdomyolysis toxicity. Rhabdomyolysis is preceded by inflammation of muscle tissue, and patients with symptoms of myalgia can be elevated in serum creatine kinase and serum spine alkaline phosphatase.

In addition, candidates need to grasp which liver function test indicators will be elevated due to taking statins.